April 22, 2016,Shenyang Jinghua Hospital and QuYun, a startup focused on assisted reproductive medicineAPPSigning of a Strategic Cooperation Agreement: Both parties will collaborate in the field of big data-driven smart healthcare for assisted reproduction, leveraging big data mining and analysis to provide precise and effective treatment plans for patients with infertility, jointly advancing“Precision Medicine”。
President Xu Peng of Jinghua Hospital and Lin Xueren, Founder of the QuYun APP, Sign Strategic Cooperation Agreement
Previously, VCBeat published an article titled “QuYun: What Is the Motive Behind Returning RMB 10 Million to Users After Its Series A Financing?》, which reported on the strategic planning of the QuYun APP. It mentioned that QuYun APP aims to establish a one-stop preconception care service platform. By facilitating doctor-patient and patient-patient interactions, enabling patient self-service, and leveraging big data analytics, the platform provides users with precise treatment plans for infertility, thereby improving the success rates of assisted reproductive technology (ART). In serving hospitals, physicians, and patients, it seeks to explore unknown areas in medicine, validate best practices in clinical activities, formulate more comprehensive healthcare strategies, and reduce the waste of medical capital and the misuse of medical supplies.
Lin Xueren, founder and CEO of the Quyun app, told VCBeat that China’s infertility rate is extremely high, with some experts estimating it has reached as high as 15%, meaning one in five couples experiences infertility. Quyun’s research also revealed that the primary need among infertile patients is to identify appropriate treatment plans to achieve pregnancy as soon as possible.
Pictured: Lin Xueren, Founder and CEO of the QuYun APP
This collaboration between QuYun and the team at Jinghua Hospital aims to provide patients with tailored solutions. Derived through big data algorithms, this approach can significantly improve patients’ success rates in in vitro fertilization (IVF).
Xu Peng, President of Shenyang Jinghua Hospital, also stated that with the continuous development and advancement of technology, a vast array of information-based, digital, and artificial intelligence technologies have become widely understood and applied. “I believe that smart healthcare entails leveraging big data technologies to organize, categorize, securely store, and scientifically analyze massive volumes of data, thereby supporting more precise medical decision-making and providing data-driven support for the advancement of medical technologies.”
Pictured: Xu Peng, President of Shenyang Jinghua Hospital
Jinghua Hospital, as one of the leading hospitals in the assisted reproductive industry in Northeast China, receives patients throughout the year2010,000 person-times, generated daily4Tens of thousands of data entries. With this massive volume of data, Jinghua Hospital chose QuYun as its strategic partner.
According to Dean Xu Peng, Quyun boasts a team of big data technology experts with advanced concepts, sophisticated skills, and extensive experience. “When the abundant data resources of Jinghua Hospital are integrated with Jiahao’s advanced big data technology, an incredible chemical reaction occurs, yielding numerous data patterns. These data patterns are more truthful than raw data and more objective than empirical experience. This will inevitably make our hospital’s clinical medical decision-making more precise and provide richer and more objective data support for the implementation of various assisted reproductive technologies and the further improvement of success rates.”
It is reported that QuYun has currently partnered with more than 20 reproductive centers in China. Most of its partners are institutions with advantages in reproductive technologies within their respective regions. Dr. Xu Peng, the hospital director, stated, “It is precisely for this reason that we are willing to contribute our data. Through such collaboration, we can also benchmark against data from other leading medical institutions, which provides valuable references for enhancing our own technical capabilities and services.”
Lin Xueren stated that QuYun’s data currently encompasses genetic testing data, clinical data, and follow-up data. It is precisely because an increasing number of hospitals, such as Jinghua Hospital, are willing to open up their data that QuYun can more rapidly advance its big data initiatives.
Furthermore, the two parties jointly launched the “Free IVF, Take a Baby Home” campaign. Lin Xueren, founder of the Quyun APP, stated, “Human assisted reproductive technology has developed rapidly in China over the past decade, resolving many practical difficulties for couples struggling with infertility. However, the high costs have deterred many ordinary citizens. Quyun and Jinghua Hospital have jointly introduced this free IVF initiative to address patients’ actual financial burdens.”